SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple's earnings are driving a lot of chatter, with the community dissecting the details and debating future performance. While some are concerned about decreased sales in China, others are optimistic due to strong iPhone demand and raised price targets from analysts. The conversation centers around whether Apple can maintain its rally and justify its valuation.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit's stock is trending amid discussions around strong earnings and future outlook, with revenue exceeding expectations. The community is focused on a potential short squeeze and the impact of AI-driven advertising, while some express concern over user growth and platform moderation policies. Bullish sentiment is countered by those anticipating an overnight tank, making for a volatile discussion.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending due to investor reactions to earnings, with concerns around increased AI spending and a substantial one-time tax charge overshadowing otherwise positive results. Community discussions focus on whether the dip presents a buying opportunity or signals deeper issues with Meta's long-term strategy, particularly its AI investments. Bond investors are showing confidence, but the stock market's initial reaction has been negative.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending due to positive community sentiment following Q3 earnings, which highlighted strong Ibsrela revenue growth and pipeline expansion, despite some challenges with Xphozah's Medicare coverage. Discussions center on the company's growth trajectory, potential profitability, and analyst price targets, with some investors anticipating further gains; however, others remain cautious due to past volatility and risks around cash flow.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending as the community discusses recent price volatility and a rejected acquisition offer, with some speculating about market manipulation and short squeezes. Despite positive catalysts like increased revenue guidance and progress in Montana mining operations, the stock's performance has sparked debate about its true value and potential government support. Discussions also involve the broader antimony sector and its strategic importance amid global trade dynamics.

UP AND TO THE RIGHT

UPRIGHT CRYPTO is gaining attention for its constructive chart patterns, with many community members noting the potential for a breakout. Discussions highlight the steady accumulation and consistent higher lows, suggesting a solid foundation. The community buzz indicates growing confidence and anticipation for a significant move.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending amid heated debates over its legitimacy, with some community members alleging fraudulent activity and liquidity removal by the founder, while others defend the project, citing its partnerships and venture backing. Discussions also revolve around its potential integration with major payment systems and the upcoming release of a 'Super App,' with some expressing optimism and others warning of a 'pump and dump' scheme.

Solid Power, Inc. engages in the manufacture and supply of power batteries. The firm develops all solid state battery cell technology that replaces the liquid or gel polymer electrolyte used in conventional lithium-ion battery cells with a sulfide-based solid electrolyte. It focuses on the development and commercialization of all solid state battery cells and solid electrolyte materials, primarily for the battery-powered electric vehicle market. The company was founded on August 3, 2011 and is headquartered in Louisville, CO.

Solid Power Inc

Solid Power Inc - Ordinary Shares - Class A

Solid Power is trending due to positive sentiment around its solid-state battery technology, particularly following news of a joint evaluation agreement with Samsung SDI and BMW. Community members are highlighting the potential for Solid Power's batteries in various sectors beyond EVs, including energy storage and aviation, while also noting the company's position as a U.S.-based entity amid concerns around reliance on China for battery technology and materials.

DLH Holdings Corp. engages in the provision of technology enabled business process outsourcing program management solutions and public health research and analytics. Its services and solutions include Defense and Veteran Health Solutions, Human Services and Solutions, Public Health and Life Sciences, and Infinibyte Cloud. The company was founded in 1969 and is headquartered in Atlanta, GA.

DLH Holdings Corp

DLHC is trending due to a recently secured $90M contract with Veteran Affairs, sparking considerable excitement within the community. Discussions revolve around the company's low float, positive net income, and potential for substantial growth, with some anticipating a significant price surge. The contract win is seen as a major catalyst, reinforcing the company's growth prospects in the government services sector.

WeRide, Inc. is a holding company, which engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers, and related sensor suites. The company was founded by Tony Xu Han and Yan Li on March 13, 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WRD is trending due to discussions surrounding its Hong Kong listing, anchor investors, and comparisons to competitor PONY. Community members are analyzing WeRide's partnerships with Uber and Grab, potential revenue streams, and its presence in various global markets. Some express frustration with the stock's performance despite positive developments, while others remain optimistic about the company's long-term potential in the autonomous vehicle sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono)

Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono) Ono Announces Results of Tender Offer to...

Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer...

Kuehn Law Encourages HIBB, CRGY, DCPH, and HCP Investors to Contact Law Firm

Kuehn Law Encourages HIBB, CRGY, DCPH, and HCP Investors to Contact Law Firm Kuehn Law Encourages HIBB, CRGY, DCPH, and HCP Investors to Contact Law Firm PR Newswire NEW YORK, June 3, 2024 NEW YORK...

SHAREHOLDER ALERT: Halper Sadeh LLC Continues to Investigate SQSP, DPSI, DCPH, HRT

SHAREHOLDER ALERT: Halper Sadeh LLC Continues to Investigate SQSP, DPSI, DCPH, HRT SHAREHOLDER ALERT: Halper Sadeh LLC Continues to Investigate SQSP, DPSI, DCPH, HRT PR Newswire NEW YORK, May 29...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, AGS, DCPH

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, AGS, DCPH SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, AGS, DCPH PR Newswire NEW YORK, May 20, 2024 NEW YORK, May 20...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, HCP, DCPH

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, HCP, DCPH SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGS, HCP, DCPH PR Newswire NEW YORK, May 13, 2024 NEW YORK, May 13...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, IONM, DPSI

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, IONM, DPSI SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, IONM, DPSI PR Newswire NEW YORK, May 10, 2024 NEW YORK, May...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, DCPH, HTLF, TBNK

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, DCPH, HTLF, TBNK SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, DCPH, HTLF, TBNK PR Newswire NEW YORK, May 2, 2024 NEW...

DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Deciphera Pharmaceuticals, Inc. (NasdaqGS...

Deep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)

Latest Ratings for DCPH
 DateFirmActionFromTo Feb 2022BarclaysDowngradesEqual-WeightUnderweight Dec 2021HC Wainwright & Co.MaintainsBuy Nov 2021Truist SecuritiesDowngradesBuyHold
 View More...

Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA.

Deciphera Pharmaceuticals Inc

Will Amazon.com ($AMZN) beat quarterly earnings? 
 
*Powered by Polymarket

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and other products, including fashion, home, beauty, electronics, Alexa Devices, sporting goods, toys, automotive, pets, baby, books, video games, musical instruments, office supplies, and more.

Current Price	$25.59
Prev Close	$25.57
Open	$25.56
Dividend Yield	N/A
50-Day Moving Average	$25.51
Beta	1.12
Avg. Volume	382,415.32
PE Ratio	-11.58

52-Week High	$25.61
52-Week Low	$9.90
Market Capitalization	$2.21B
EPS (Annual)	N/A
Price to Book	6.65
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

DCPH
Deciphera Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DCPH News

DCPHDeciphera Pharmaceuticals Inc